
Materials & Chemicals · NSE / BSE
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a specialty chemical manufacturer engaged in producing structure directing agents, phase transfer catalysts, pharmaceutical and agrochemical intermediates, and other specialty chemicals, and is among the largest producers of SDAs for zeolites in India. The company caters to a wide range of industries including automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceuticals, personal care, and others, with products sold in India and exported to over 25 countries such as the USA, Germany, South Africa, China, and the UK. Exports contributed around 76% of its revenue in FY 2020, and its customer base includes leading names like Merck, Bayer AG, Laurus Labs, Navin Fluorine, Atul Limited, SRF Limited, and Divi’s Laboratories, with manufacturing facilities located at Ankleshwar and Dahej in Gujarat.
Price Band
₹1073 – ₹1083
Issue Size
₹500 Cr
Lot Size
13 shares
GMP
+102.5%
Est. Listing
₹2193
at current GMP
Subscribed
—
Open
16 Jul 2021
Close
20 Jul 2021
Allotment
26 Jul 2021
Refund
27 Jul 2021
Demat Credit
28 Jul 2021
Listing
29 Jul 2021
Overall Subscription
0.00x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
0.00x
High Net-Worth
Retail (RII)
0.00x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| Qualified Institutional (QIB) | 2,308,403 | — | 0.00x |
| Non-Institutional (NII / HNI) | 692,521 | — | 0.00x |
| Retail Individual (RII) | 1,615,882 | — | 0.00x |
| Total | 4,616,806 | 0 | 0.00x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 124,299 | 124,299 | 1.00x |
| HNIs (10L +) | 795 | 795 | 1.00x |
| HNIs (2-10L) | 3,805 | 3,805 | 1.00x |
| Total Applications | 128,899 | 128,899 | 1.00x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Tatva Chintan Pharma Chem Limited is bringing an initial public offering (IPO) in the Materials & Chemicals sector with an aggregate issue size of ₹500 Crores. The shares are offered at a price band of ₹1073 to ₹1083 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 13 shares (approx. ₹14,079 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2021-07-28, while un-allotted funds or UPI block mandates will be released on 2021-07-27.
The latest Grey Market Premium (GMP) for Tatva Chintan Pharma Chem Limited IPO is ₹1110 per equity share. Based on the upper price band of ₹1073 to ₹1083 per equity share, the estimated listing price is ₹2193 (+102.5% expected listing gain).
With a lot size of 13 shares and current GMP of ₹1110, the expected profit per application lot is approx ₹14,430 (+102.5% gain). Minimum application cost is approx ₹14,079.
The Tatva Chintan Pharma Chem Limited IPO aggregate issue size is ₹500 Crores with an equity price band set at ₹1073 to ₹1083 per equity share. The retail lot size is 13 shares requiring a minimum capital outlay of approx. ₹14,079.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 0.00x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Link Intime India Private Limited) and the BSE status verification website on or around 2021-07-26. Investors can verify status using PAN card or application number.
Tatva Chintan Pharma Chem Limited shares are scheduled to list on NSE and BSE on 2021-07-29.